11/22
08:42 am
vrpx
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™ [Yahoo! Finance]
High
Report
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™ [Yahoo! Finance]
11/22
08:30 am
vrpx
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
High
Report
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
11/21
04:05 pm
vrpx
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
High
Report
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
11/18
10:28 am
vrpx
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering [Yahoo! Finance]
High
Report
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering [Yahoo! Finance]
11/18
10:23 am
vrpx
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
Medium
Report
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
11/15
04:16 pm
vrpx
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
High
Report
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/15
04:09 pm
vrpx
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
High
Report
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
11/13
09:15 am
vrpx
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
1/17
04:32 pm
vrpx
Form S-1/A Virpax Pharmaceuticals,
Low
Report
Form S-1/A Virpax Pharmaceuticals,
1/15
04:32 pm
vrpx
Form S-1/A Virpax Pharmaceuticals,
Medium
Report
Form S-1/A Virpax Pharmaceuticals,
1/15
04:05 pm
vrpx
Form 8-K Virpax Pharmaceuticals, For: Jan 15
High
Report
Form 8-K Virpax Pharmaceuticals, For: Jan 15
1/8
04:11 pm
vrpx
Form 3 Virpax Pharmaceuticals, For: Dec 17 Filed by: Panis Jaydriane
Low
Report
Form 3 Virpax Pharmaceuticals, For: Dec 17 Filed by: Panis Jaydriane
1/7
04:31 pm
vrpx
Form 8-K Virpax Pharmaceuticals, For: Jan 06
Medium
Report
Form 8-K Virpax Pharmaceuticals, For: Jan 06
1/6
04:05 pm
vrpx
Form 3 Virpax Pharmaceuticals, For: Nov 18 Filed by: Chaudhry Usama
Low
Report
Form 3 Virpax Pharmaceuticals, For: Nov 18 Filed by: Chaudhry Usama
12/30
04:47 pm
vrpx
Form S-1 Virpax Pharmaceuticals,
High
Report
Form S-1 Virpax Pharmaceuticals,
12/30
04:06 pm
vrpx
Form 8-K Virpax Pharmaceuticals, For: Dec 30
High
Report
Form 8-K Virpax Pharmaceuticals, For: Dec 30
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register